share_log

Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update

Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW) Short Interest Update

克拉魯斯治療控股公司(納斯達克代碼:CRXTW)空頭股數更新
Financial News Live ·  2022/08/29 13:51

Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXTW – Get Rating) was the target of a significant drop in short interest in August. As of August 15th, there was short interest totalling 13,500 shares, a drop of 43.5% from the July 31st total of 23,900 shares. Based on an average daily volume of 43,400 shares, the short-interest ratio is presently 0.3 days.

克拉魯斯治療控股公司(納斯達克:CRXTW-GET評級)是空頭股數8月份大幅下跌的目標。截至8月15日,空頭股數共有13,500股,較7月31日的23,900股減少了43.5%。以日均成交量43,400股計算,目前短息比率為0.3天。

Clarus Therapeutics Stock Down 41.4 %

Clarus Treateutics股價下跌41.4%

CRXTW stock traded down $0.01 during midday trading on Monday, reaching $0.02. The company had a trading volume of 3,205 shares, compared to its average volume of 133,019. The stock's 50 day moving average price is $0.06. Clarus Therapeutics has a fifty-two week low of $0.02 and a fifty-two week high of $1.19.

在週一午盤交易中,CRXTW股價下跌0.01美元,至0.02美元。該公司的成交量為3,205股,而其平均成交量為133,019股。該股的50日移動均線價格為0.06美元。Clarus Treeutics的52周低點為0.02美元,52周高位為1.19美元。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Clarus Therapeutics (CRXTW)
  • What is the NASDAQ Stock Exchange?
  • Should You Be Bullish On Barrick Gold?
  • The Institutions Choose Dollar General For The 2nd Half
  • The S&P 500 Just Flashed A Significant Signal
  • Why Trading Volume is Unusually High on These 3 Stocks
  • 免費獲取StockNews.com關於Clarus治療公司(CRXTW)的研究報告
  • 什麼是納斯達克證券交易所?
  • 你應該看好巴里克·戈爾德嗎?
  • 機構選擇美元通貨作為下半年
  • 標準普爾500指數剛剛發出了一個重要信號
  • 這三隻股票的成交量為何異常高

Receive News & Ratings for Clarus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

接受Clarus治療日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Clarus Treateutics和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論